BEONE MEDICINES 06160·

Gross margin --------------------85.98%--79.77%6.21%84.55%4.78%85.09%0.55%88.50%3.40% Net margin -11141.78%---37.64%11104.14%-------------123.93%---141.52%17.59%-35.86%105.66%-17.06%18.80%5.43%22.49% ROE -33.78%---14.39%19.39%-------------23.77%---45.71%21.94%-24.93%20.79%-19.35%5.58%6.58%25.93% ROA -29.38%---9.27%20.11%-------------17.08%---31.41%14.33%-15.19%16.22%-10.89%4.30%24.63%35.52% Revenue growth ----23703.18%------------------31.49%--76.60%45.11%56.01%20.59%36.65%19.36% Attributable profit growth ----19.45%-------------------50.15%--55.25%105.40%25.78%29.47%143.51%117.73% Debt-to-assets 13.04%--34.06%21.02%------------28.15%--31.29%3.14%39.07%7.78%43.72%4.65%46.74%3.02% Current ratio 10.68--6.204.48------------4.76--3.551.212.321.221.800.523.411.61 Operating cash flow / net profit 0.75---0.130.88------------0.89--0.750.141.310.570.221.093.933.71 Operating cash flow / revenue -8365.70%--5.01%8370.71%-------------110.41%---105.70%4.71%-47.07%58.63%-3.72%43.35%21.35%25.07%

Gross margin 86.45%--86.32%--89.38%2.93%89.06%2.75% Net margin 3.93%--5.73%--14.43%10.50%16.62%10.89% Revenue growth --------32.31%--32.86%-- Attributable profit growth --------385.79%--285.19%-- Debt-to-assets --------43.61%--41.06%-- Current ratio --------3.40------ Operating cash flow / net profit 3.22--3.22--1.431.791.381.84 Operating cash flow / revenue 12.65%--18.47%--20.64%7.99%22.96%4.49%

Revenue 1.07M--254.69M23703.18%------------7.50B--9.86B31.49%17.41B76.60%27.17B56.01%37.13B36.65% Other income and gains 443.00K--21.08M4657.79%-------------------------------- Cost of sales 0--98.03M---------------------------------- Gross profit --------------------6.45B--7.87B21.99%14.72B87.18%23.12B57.02%32.86B42.12% Selling and distribution expenses --------------------6.31B--8.90B40.98%10.68B20.01%13.16B23.23%14.63B11.15% Net finance costs 383.00K--4.11M972.58%------------------------156.74M--409.32M161.14% Income tax 54.00K--30.73M56807.41%------------122.59M--297.93M143.03%395.72M32.82%803.56M103.06%913.19M13.64% Operating profit -117.06M---82.15M29.82%-------------9.17B---12.46B35.88%-8.55B31.37%-4.08B52.25%3.14B176.95% Profit before tax -119.16M---65.14M45.34%-------------9.17B---13.66B48.91%-5.85B57.17%-3.83B34.50%2.93B176.47% Net profit -119.22M---95.87M19.59%-------------9.29B---13.96B50.15%-6.24B55.25%-4.63B25.78%2.02B143.51% Net profit attributable to owners -119.22M---96.03M19.45%-------------9.29B---13.96B50.15%-6.24B55.25%-4.63B25.78%2.02B143.51%

Revenue 2.43B--3.84B--3.22B32.31%5.11B32.86% Other income and gains -----6.86M------14.22M307.17% Cost of sales 329.61M--526.12M--341.75M3.68%558.64M6.18% Gross profit 2.10B--3.32B--2.88B36.80%4.55B37.09% Selling and distribution expenses 997.20M--1.53B--1.15B15.15%1.74B14.12% Net finance costs ----31.36M------115.03M266.80% Income tax 24.86M--47.18M--107.31M331.67%132.96M181.81% Operating profit 98.99M--262.10M--574.95M480.83%993.62M279.10% Profit before tax 120.45M--267.61M--571.67M374.62%982.03M266.96% Net profit 95.59M--220.43M--464.36M385.79%849.07M285.19%

Cash and cash equivalents 87.51M--239.60M173.79%------------27.90B--26.95B3.40%22.46B16.64%18.89B15.93%4.61B75.59% Trade and bills receivables 0--29.43M--------------3.08B--1.21B60.85%2.54B110.26%4.86B91.71%865.08M82.20% Inventories 0--10.93M--------------1.55B--1.97B27.12%2.95B49.88%3.56B20.73%608.23M82.91% Total current assets 374.40M--929.80M148.35%------------48.54B--36.27B25.29%29.77B17.91%28.69B3.62%43.81B52.70% Total assets 405.81M--1.03B154.85%------------54.42B--44.43B18.36%41.12B7.45%42.56B3.51%8.19B80.76% Total current liabilities 35.06M--149.99M327.83%------------10.20B--10.23B0.29%12.82B25.35%15.92B24.19%12.85B19.26% Total liabilities 52.91M--352.26M565.82%------------15.32B--13.90B9.27%16.06B15.56%18.61B15.85%3.83B79.43% Equity attributable to owners 352.91M--667.14M89.04%------------39.10B--30.53B21.92%25.05B17.93%23.95B4.39%30.65B27.97% Total equity 352.91M--681.94M93.24%------------39.10B--30.53B21.92%25.05B17.93%23.95B4.39%4.36B81.79%

Cash and cash equivalents --------5.28B--5.87B-- Trade and bills receivables --------1.06B--1.09B-- Inventories --------732.60M--807.92M-- Total current assets --------7.22B------ Total assets --------9.18B--9.88B-- Total current liabilities --------2.12B------ Total liabilities --------4.00B--4.06B-- Total equity --------5.17B--5.82B--

Net cash from operating activities -89.51M--12.75M114.25%-------------8.28B---10.42B25.88%-8.20B21.35%-1.01B87.67%7.93B884.00% Net cash from investing activities -221.85M---356.32M60.61%------------4.08B--7.50B83.66%424.99M94.33%-3.94B1027.49%-1.94B50.76% Net cash from financing activities 380.90M--490.36M28.74%------------23.19B---132.13M100.57%2.95B2332.57%1.39B52.86%7.45B435.50% Net change in cash 69.64M--152.09M118.38%------------19.08B---3.54B118.54%-4.88B37.98%-3.93B19.40%13.85B452.16%

Net cash from operating activities 307.68M--710.23M--664.16M115.86%1.17B65.14% Net cash from investing activities -188.55M---237.82M---94.86M49.69%-130.62M45.07% Net cash from financing activities 1.25M--962.52M--62.58M4914.26%164.77M82.88% Net change in cash 147.34M--1.47B--671.03M355.43%1.26B14.62%